Life science News and Research

RSS

MGI Tech launches whole workflow solution for agricultural large-scale low-pass whole genome sequencing at PAG Asia 2024

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced a highly efficient whole workflow solution for agricultural large-scale Low-pass whole genome sequencing (Low-pass WGS) based on its proprietary DNBSEQTM platforms during this year’s International Plant and Animal Genome Conference Asia (PAG Asia 2024), taking place on June 5-7 in Shenzhen, China.

From MGI 7 Jun 2024

MGI Tech unveils new european headquarters in Berlin, Germany

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the opening of its new European headquarters in Berlin, Germany to support the life science community across the region.

From MGI 7 Jun 2024

MGI Tech shares new data on core DNEBSEQ technology and showcases latest sequencing innovations at ESHG 2024

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today showcased its cutting-edge technologies via a Corporate Satellite Meeting at this year’s European Society of Human Genetics (ESHG) conference in Berlin, Germany.

From MGI 7 Jun 2024

MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, recently set a new record for sequencing applications by successfully running sample testing on its cutting-edge DNBSEQ-E25 and DNBSEQ-G99 platforms on Mount Everest.

From MGI 7 Jun 2024

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the extension of its global sales network with the appointment of two distributors: Paralab and ProAnalytics. The new application specific distributors increase H.E.L’s sales reach and improve access to technical and field application support for biotechnology and chemical synthesis customers in Europe and the US.

From H.E.L Group 6 Jun 2024

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.

4 Jun 2024

SCIEX launches new data independent acquisition, ZT Scan DIA, at ASMS 2024

At ASMS 2024, SCIEX, a global leader in life science analytical technologies, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition (DIA) that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

From SCIEX 4 Jun 2024

The SCIEX 7500+ system launches at ASMS 2024

At ASMS 2024, SCIEX, a global leader in life science analytical technologies, launches the SCIEX 7500+ system, the newest mass spectrometer in the SCIEX quantitative portfolio, building upon a legacy of reliable, sensitive quantitation.

From SCIEX 4 Jun 2024

SCIEX and Mass Analytica collaborate to advance artificial intelligence quantitation software

At ASMS 2024, SCIEX, a global leader in life science analytical technologies, in collaboration with Mass Analytica, presents artificial intelligence quantitation (AI quant) software. AI quant harnesses the capabilities of artificial intelligence and machine learning to process data and produce insights in a matter of moments, freeing up operator time and boosting productivity.

From SCIEX 4 Jun 2024

SolasCure selected for innovate UK global incubator programme in houston

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK’s Global Incubator Programme in Houston, US.

From SolasCure 3 Jun 2024

Discover how SciY empowers scientists

In this interview, NewsMedical talks to Santi Dominguez about the genesis of SCiY, and how the consortium intends to empower scientists and researchers.

From SciY 31 May 2024

H.E.L Group extends sales and support with appointment of specialist distributors

From H.E.L Group 31 May 2024

RNAConnect, Inc. formally launches to drive RNA analysis

RNAConnect, a pioneering life science reagent company, officially launches today, promising groundbreaking solutions for exploring the real-world diversity of RNA sequence and structure.

From RNA Connect 29 May 2024

Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as Director of Sales for Europe, Middle East, and Africa (EMEA). Curtis’ appointment will strengthen the Company’s market position in these regions as it progresses ambitious plans for future growth and commercial success.

From Sphere Fluidics 23 May 2024

Refeyn strengthens capability with new US Headquarters in Boston area

Refeyn, the pioneer of mass photometry technology, is continuing to strengthen the deployment of its unique bioanalytical tools with the planned Grand Opening of its new US Headquarters and Customer Interaction Center, in conjunction with the third annual Mass Photometry Summit 2024. Following the summit, highlighting the very latest advances in mass photometry, to be held in the Boston area on May 22, Refeyn will officially open its new 10,000 sq. ft. HQ in the heart of Waltham’s Biotech Hub in Greater Boston, Massachusetts, on May 23.

From Refeyn 23 May 2024

Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.

From Refeyn 22 May 2024

Twendee X shows promise in reducing oxidative stress in systemic sclerosis

Autoimmune diseases occur when the body's immune system attacks healthy cells instead of protecting them.

17 May 2024

Oncotype DX Breast Recurrence Score test recommended by NICE for lymph node-positive breast cancer patients

Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to more effectively target chemotherapy treatment for women who have hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), early-stage breast cancer involving up to three positive nodes and who have been through the menopause.

15 May 2024

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

From ArgusEye AB 13 May 2024

New tool more accurately predicts an individual's 10-year risk of cardiovascular diseases

Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

8 May 2024

Life science News and Research

MGI Tech launches whole workflow solution for agricultural large-scale low-pass whole genome sequencing at PAG Asia 2024

MGI Tech unveils new european headquarters in Berlin, Germany

MGI Tech shares new data on core DNEBSEQ technology and showcases latest sequencing innovations at ESHG 2024

MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

H.E.L Group extends sales and support with appointment of specialist distributors

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

SCIEX launches new data independent acquisition, ZT Scan DIA, at ASMS 2024

The SCIEX 7500+ system launches at ASMS 2024

SCIEX and Mass Analytica collaborate to advance artificial intelligence quantitation software

SolasCure selected for innovate UK global incubator programme in houston

Discover how SciY empowers scientists

H.E.L Group extends sales and support with appointment of specialist distributors

RNAConnect, Inc. formally launches to drive RNA analysis

Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets

Refeyn strengthens capability with new US Headquarters in Boston area

Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

Twendee X shows promise in reducing oxidative stress in systemic sclerosis

Oncotype DX Breast Recurrence Score test recommended by NICE for lymph node-positive breast cancer patients

ArgusEye closes €2.8 million funding to accelerate bioprocessing

New tool more accurately predicts an individual's 10-year risk of cardiovascular diseases

Pittcon Highlights: Bioanalytical and Life Sciences eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News